HuGE Literature Finder
Records
1
-
4
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma. Frontiers in oncology 2022 12 12 1042525. Nannini Margherita, Repaci Andrea, Ricco Gianluca, Ianni Manuela, Golemi Arber, Maiolo Vincenzo, Ferrari Marco, Natali Filippo, Rizzini Elisa Lodi, Monari Fabio, Solaroli Erica, De Leo Antonio, Maloberti Thais, Pantaleo Maria A, De Biase Dario, Tallini Giovan |
Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing. Cancer science 2021 Oct . Shi Minke, Wang Weiran, Zhang Jinku, Li Bobo, Lv Dongxiao, Wang Danhua, Wang Sizhen, Cheng Dezhi, Ma Tongh |
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs. Lung cancer (Amsterdam, Netherlands) 2016 Jun . Malapelle Umberto, Morra Francesco, Ilardi Gennaro, Visconti Roberta, Merolla Francesco, Cerrato Aniello, Napolitano Virginia, Monaco Roberto, Guggino Gianluca, Monaco Guglielmo, Staibano Stefania, Troncone Giancarlo, Celetti Ange |
Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2008 May 105 (20): 7269-74. Jazdzewski Krystian, Murray Elizabeth L, Franssila Kaarle, Jarzab Barbara, Schoenberg Daniel R, de la Chapelle Albe |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: